The Magnifying LeNS highlights the latest in the lung cancer treatment landscape as seen by GO2 for Lung Cancer’s Science and Research team. Explore our full-format newsletter archive and sign up to receive the Magnifying LeNS to your inbox on a quarterly basis.
ASCO 2023: Advances in Early-Stage Lung Cancer Research
By Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer While the past decade has seen the development of many new therapies for lung cancer, these drugs are typically first approved for metastatic cancer (cancer that has [...]